The Chair called Vote 5c under Canadian Institutes of Health Research.

The Minister made a statement and, with Shalene Curtis-Micallef, Robert Ianiro, Paul Hébert and Kendall Weber, answered questions.

By unanimous consent, the Chair called Vote 5c under Canadian Institutes of Health Research, Vote 10c under Department of Health, Votes 1c and 10c under Public Health Agency of Canada.

Vote 5c under Canadian Institutes of Health Research, Vote 10c under Department of Health, Votes 1c and 10c under Public Health Agency of Canada carried on division.

ORDERED, — That the Chair report Vote 5c under Canadian Institutes of Health Research, Vote 10c under Department of Health, Votes 1c and 10c under Public Health Agency of Canada to the House.

At 4:36 p.m., the meeting was suspended.

At 4:40 p.m., the meeting resumed.

Kendall Weber, Paul Hébert, Pamela Aung-Thin, Nancy Hamzawi, Robert Ianiro, and Shalene Curtis-Micallef answered questions.

Matt Strauss moved, — That the committee order the production of the following complete and fully unredacted documents:

a) the audit conducted by MNP that assessed the design of the financial controls framework for the Canadian Dental Care Plan;

b) all briefing notes, recommendations, and documents provided to the Minister of Health or the Minister’s Office regarding the October 17, 2025 change to reimbursement criteria for laboratory fees under the Canadian Dental Care Plan;

c) the number of Canadian Dental Care Plan patients who received prior authorization for treatments involving laboratory fees before October 17, 2025 but received reduced reimbursement after that date;

d) all correspondence between Health Canada and Sun Life Financial regarding the change to reimbursement criteria for laboratory fees under the Canadian Dental Care Plan;

e) all analysis conducted on the impact the Canadians Dental Care Plan will have to dental schools in Canada;

f) all applications and corresponding signed agreements, except with Quebec, including appendices and annexes, from for the Substance Use and Addictions Program since 2020 as requested by the committee on December 9, 2025;

g) all applications and corresponding signed agreements, except with Quebec, including appendices and annexes from for the Emergency Treatment Fund since 2020 as requested by the committee on December 9, 2025;

h) all applications received by the government to administer the Vaccine Injury Support Program, including all recommendation documents provided to the Minister’s Office on the applicants;

i) all documents related to PrescribeIT, including: the 2017 contract between Canada Health Infoway and TELUS Health; all amendments, renewals, and change orders since 2017; all intellectual property ownership agreements; the 2026 termination notice and all clauses, provisions, or records relating to termination and penalties; a list of all payments made by Canada Health Infoway to TELUS Health since 2017; and all recommendation documents provided to the Minister’s Office regarding PrescribeIT funding, operations, and termination;

j) all agreements between Canadian Blood Services and Grifols related to the manufacture, processing, or supply of both blood and plasma-derived products, including all amendments and related agreements;

k) all quarterly reports and underlying data submitted to Health Canada’s Office of Controlled Substances by provincial or territorial Ministers of Health, except from Quebec, pursuant to the subsection 56(1) class exemption for Urgent Public Health Need Sites.

At 5:31 p.m., the meeting was suspended.

At 5:37 p.m., the meeting resumed.

Debate arose thereon.

At 5:49 p.m., the meeting was suspended.

At 5:50 p.m., the meeting resumed.

The debate resumed on the amendment of Maggie Chi.

At 5:54 p.m., the meeting was suspended.

At 3:36 p.m., on Tuesday, March 24, 2026, Hedy Fry took the chair and the meeting resumed in public.

It was agreed, — That the proposed supplementary budget in the amount of $250, for the study of Bill C-234, An Act respecting the establishment and award of a Living Donor Recognition Medal, be adopted.

It was agreed, — That the proposed budget in the amount of $1,000, for the study of Supplementary Estimates (C), 2025-26: Vote 5c under Canadian Institutes of Health Research, Vote 10c under Department of Health, Votes 1c and 10c under Public Health Agency of Canada, be adopted.

It was agreed, — That the deadline to submit witnesses for the study of Bill C-224, An Act to amend the Food and Drugs Act (natural health products) be Thursday, April 2, 2026.

It was agreed, — That the deadline for the submission of briefs in relation to the study of Canada’s pharmaceutical sovereignty be Tuesday, May 5, 2026.

The committee resumed consideration of the motion of Matt Strauss moved on Thursday, March 12, 2026, which read as follows:

That the committee order the production of the following complete and fully unredacted documents:

a) the audit conducted by MNP that assessed the design of the financial controls framework for the Canadian Dental Care Plan;

b) all briefing notes, recommendations, and documents provided to the Minister of Health or the Minister’s Office regarding the October 17, 2025, change to reimbursement criteria for laboratory fees under the Canadian Dental Care Plan;

c) the number of Canadian Dental Care Plan patients who received prior authorization for treatments involving laboratory fees before October 17, 2025, but received reduced reimbursement after that date;

d) all correspondence between Health Canada and Sun Life Financial regarding the change to reimbursement criteria for laboratory fees under the Canadian Dental Care Plan;

e) all analysis conducted on the impact the Canadians Dental Care Plan will have to dental schools in Canada;

f) all applications and corresponding signed agreements, except with Quebec, including appendices and annexes, from for the Substance Use and Addictions Program since 2020 as requested by the committee on December 9, 2025;

g) all applications and corresponding signed agreements, except with Quebec, including appendices and annexes from for the Emergency Treatment Fund since 2020 as requested by the committee on December 9, 2025;

h) all applications received by the government to administer the Vaccine Injury Support Program, including all recommendation documents provided to the Minister’s Office on the applicants;

i) all documents related to PrescribeIT, including: the 2017 contract between Canada Health Infoway and TELUS Health; all amendments, renewals, and change orders since 2017; all intellectual property ownership agreements; the 2026 termination notice and all clauses, provisions, or records relating to termination and penalties; a list of all payments made by Canada Health Infoway to TELUS Health since 2017; and all recommendation documents provided to the Minister’s Office regarding PrescribeIT funding, operations, and termination;

j) all agreements between Canadian Blood Services and Grifols related to the manufacture, processing, or supply of both blood and plasma-derived products, including all amendments and related agreements;

k) all quarterly reports and underlying data submitted to Health Canada’s Office of Controlled Substances by provincial or territorial Ministers of Health, except from Quebec, pursuant to the subsection 56(1) class exemption for Urgent Public Health Need Sites.

And that these documents be submitted, unredacted and in both official languages, to the committee clerk by no later than April 17, 2026; and that any failure by the government to fully comply with this order be reported to the House by no later than April 20, 2026.

And of the amendment of Maggie Chi moved on Thursday, March 12, 2026, which read as follows:

That the motion be amended by deleting paragraphs e) and j).

The debate continued on the motion of Matt Strauss.

A point of order was raised as to the admissibility of the proposed amendment.

RULING BY THE CHAIR

The Chair ruled the amendment in order, as it was relevant to the motion under consideration.

Whereupon, Dan Mazier appealed the decision of the Chair.

The question: "Shall the decision of the Chair be sustained?" was put and the decision was overturned on the following recorded division:

YEAS: Maggie Chi, Doug Eyolfson, Helena Jaczek, Sonia Sidhu — 4;

NAYS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5.

The debate resumed on the motion.

At 4:11 p.m., the meeting was suspended.

At 4:24 p.m., the meeting resumed.

The debate resumed on the amendment of Helena Jaczek.

A point of order was raised as to the admissibility of the proposed amendment.

RULING BY THE CHAIR

The Chair ruled the amendment in order, as it was relevant to the motion under consideration.

Whereupon, Matt Strauss appealed the decision of the Chair.

The question: "Shall the decision of the Chair be sustained?" was put and the decision was overturned on the following recorded division:

YEAS: Maggie Chi, Doug Eyolfson, Helena Jaczek, Sonia Sidhu — 4;

NAYS: Burton Bailey, Maxime Blanchette-Joncas, Helena Konanz, Dan Mazier, Matt Strauss — 5.

The debate resumed on the motion.

At 4:46 p.m., the meeting was suspended.

At 4:52 p.m., the meeting resumed.

The debate continued on the amendment of Sonia Sidhu.

Maxime Blanchette-Joncas moved, — That the debate be now adjourned.

The question was put on the motion and it was agreed to on the following recorded division:

YEAS: Maxime Blanchette-Joncas, Maggie Chi, Doug Eyolfson, Helena Jaczek, Sonia Sidhu — 5;

NAYS: — 0.

On motion of Maggie Chi, it was agreed, — That the committee do now adjourn.